| IL1RAP potentiates multiple oncogenic signaling pathways in AML K Mitchell, L Barreyro, TI Todorova, SJ Taylor, I Antony-Debré, ... Journal of Experimental Medicine 215 (6), 1709-1727, 2018 | 85 | 2018 |
| The DNA dioxygenase Tet1 regulates H3K27 modification and embryonic stem cell biology independent of its catalytic activity S Chrysanthou, Q Tang, J Lee, SJ Taylor, Y Zhao, U Steidl, D Zheng, ... Nucleic acids research 50 (6), 3169-3189, 2022 | 45 | 2022 |
| Flt3 inhibitor AC220 is a potent therapy in a mouse model of myeloproliferative disease driven by enhanced wild-type Flt3 signaling SJ Taylor, SA Dagger, CBF Thien, ME Wikstrom, WY Langdon Blood, The Journal of the American Society of Hematology 120 (19), 4049-4057, 2012 | 44 | 2012 |
| Preventing chemotherapy-induced myelosuppression by repurposing the FLT3 inhibitor quizartinib SJ Taylor, JM Duyvestyn, SA Dagger, EJ Dishington, CA Rinaldi, ... Science translational medicine 9 (402), eaam8060, 2017 | 41 | 2017 |
| MDMX acts as a pervasive preleukemic-to-acute myeloid leukemia transition mechanism K Ueda, R Kumari, E Schwenger, JC Wheat, O Bohorquez, ... Cancer Cell 39 (4), 529-547. e7, 2021 | 26 | 2021 |
| Runx1 promotes murine erythroid progenitor proliferation and inhibits differentiation by preventing Pu. 1 downregulation MA Willcockson, SJ Taylor, S Ghosh, SE Healton, JC Wheat, TJ Wilson, ... Proceedings of the National Academy of Sciences 116 (36), 17841-17847, 2019 | 24 | 2019 |
| Loss of c-Cbl E3 ubiquitin ligase activity enhances the development of myeloid leukemia in FLT3-ITD mutant mice SJ Taylor, CBF Thien, SA Dagger, JM Duyvestyn, CS Grove, BH Lee, ... Experimental hematology 43 (3), 191-206. e1, 2015 | 18 | 2015 |
| Dasatinib targets B-lineage cells but does not provide an effective therapy for myeloproliferative disease in c-Cbl RING finger mutant mice JM Duyvestyn, SJ Taylor, SA Dagger, M Orandle, HC Morse III, CBF Thien, ... PloS one 9 (4), e94717, 2014 | 13 | 2014 |
| Influence of influenza A infection on capsaicin-induced responses in murine airways SJ Taylor, TS Mann, PJ Henry Journal of Pharmacology and Experimental Therapeutics 340 (2), 377-385, 2012 | 12 | 2012 |
| Dasatinib promotes the activation of quiescent hematopoietic stem cells in mice JM Duyvestyn, SJ Taylor, SA Dagger, WY Langdon Experimental hematology 44 (5), 410-421. e5, 2016 | 9 | 2016 |
| The targeting of human and mouse B lymphocytes by dasatinib MP Oksvold, JM Duyvestyn, SA Dagger, SJ Taylor, L Forfang, ... Experimental hematology 43 (5), 352-363. e4, 2015 | 8 | 2015 |
| DNA selection by the master transcription factor PU. 1 JR Terrell, SJ Taylor, AL Schneider, Y Lu, TN Vernon, S Xhani, ... Cell reports 42 (7), 2023 | 5 | 2023 |
| Metabolic strugGLS after FLT3 inhibition in AML SJ Taylor, U Steidl blood 131 (15), 1631-1632, 2018 | 2 | 2018 |
| Sleeping through the storm: Preventing myelosuppression with quizartinib SJ Taylor, WY Langdon Oncotarget 8 (51), 88255, 2017 | 1 | 2017 |
| Hitting the snooze button: Inducing quiescence with the FLT3 inhibitor quizartinib protects hematopoietic progenitors from chemotherapy SJ Taylor, WY Langdon Molecular & Cellular Oncology 4 (6), e1378156, 2017 | | 2017 |
| The FLT3 Inhibitor Quizartinib Provides a Novel Strategy to Inhibit Chemotherapy-Induced Myelosuppression WY Langdon, SJ Taylor, JM Duyvestyn, SA Dagger, GS Vassiliou Blood 128 (22), 4041, 2016 | | 2016 |
| Characterising the effects of FLT3 inhibitor AC220 on haematopoiesis and myeloproliferative neoplasms SJ Taylor | | 2015 |
